Related Experiment Video
Updated: Jul 5, 2025

Author Spotlight: Flow Cytometric Determination of Pyroptosis in Avian Cells
Published on: May 31, 2024
Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis
Jiasong Pan1, Yuanyuan Li1, Wenqing Gao1
1Department of Neurology, Huashan Hospital, State Key Laboratory of Genetic Engineering and School of Life Sciences, Fudan University, Shanghai, China.
Abstract:
Gasdermin-E (GSDME), the executioner of pyroptosis when cleaved by caspase 3, plays a crucial role in tumor defense and the response to chemotherapy drugs in cells. So far, there are poorly known mechanisms for the expression regulation of GSDME during cell death. Here, we identify the transcription factor Sp1 (Specificity protein 1) as a positive regulator of GSDME-mediated pyroptosis. Sp1 directly interacts with the GSDME promoter at -36 ~ -28 site and promotes GSDME gene transcription. Further, Sp1 knockdown or inhibition suppresses GSDME expression, thus reducing chemotherapy drugs (topotecan, etoposide, doxorubicin, sorafinib and cisplatin) induced cell pyroptosis. The regulation process synergizes with STAT3 (Signal transducer and activator of transcription 3) activity and antagonizes with DNA methylation but barely affects GSDMD-mediated pyroptosis or TNF-induced necroptosis. Our current finding reveals a new regulating mechanism of GSDME expression, which may be a viable target for the intervention of GSDME-dependent inflammatory diseases and cancer therapy.
Insights
Specificity protein 1 (Sp1) activates Gasdermin-E (GSDME) expression, a key driver of pyroptosis during cancer therapy. This finding reveals a new regulatory mechanism for GSDME, crucial for understanding cell death and developing new cancer treatments.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Gasdermin-E (GSDME) is essential for pyroptosis, a programmed cell death pathway critical in tumor defense and chemotherapy response.
- Mechanisms regulating GSDME expression during cell death remain largely unknown.
Purpose of the Study:
- To identify and characterize novel regulators of GSDME gene expression.
- To elucidate the role of transcription factors in controlling GSDME-mediated pyroptosis.
Main Methods:
- Luciferase reporter assays to assess promoter activity.
- Chromatin immunoprecipitation to confirm Sp1 binding to the GSDME promoter.
- Western blotting and quantitative PCR to measure GSDME expression levels.
- Cell viability assays and pyroptosis assessment following drug treatment and Sp1 manipulation.
Main Results:
- Specificity protein 1 (Sp1) was identified as a positive regulator of GSDME expression.
- Sp1 directly binds to the GSDME promoter region (-36 to -28) and enhances its transcription.
- Sp1 knockdown or inhibition significantly reduced GSDME expression and chemotherapy-induced pyroptosis.
- This regulation synergizes with STAT3 activity and is antagonized by DNA methylation.
Conclusions:
- Sp1 is a novel positive regulator of GSDME-mediated pyroptosis.
- Understanding Sp1-GSDME interaction provides insights into GSDME regulation during cell death.
- This pathway represents a potential therapeutic target for GSDME-dependent inflammatory diseases and cancer therapy.
More Related Videos
Related Concept Videos
Master Transcription Regulators
General Transcription Factors
TGF - β Signaling Pathway
RNA Polymerase II Accessory Proteins
Transcription Factors
Cell Specific Gene Expression

